Skip to main content

Table 1 Demographics and expenditures of patients with/without ESRD who received CABG

From: Hospital costs and prognosis in end-stage renal disease patients receiving coronary artery bypass grafting

 

ESRD

Non-ESRD

P value

Absolute standardized difference

N = 48

N = 96

Age (mean ± SD)

62.04 ± 10.04

61.63 ± 11.77

.838

0.0375

39 (%)

1 (2.1)

3 (3.1)

.954

 

 40–49

6 (12.5)

10 (10.4)

 

 50–59

15 (31.3)

29 (30.2)

 

 60–69

12 (25.0)

29 (30.2)

 

70

14 (29.2)

25 (26.0)

 

Sex (%)

 Male

32 (66.7)

66 (68.8)

.800

0.0449

 Female

16 (33.3)

30 (31.3)

Comorbidities (%)

 Hypertension

34 (70.8)

62 (64.6)

.453

0.1328

 Diabetes

32 (66.7)

69 (71.9)

.520

0.1129

 Myocardial infarction

14 (29.2)

31 (32.3)

.703

0.0672

 Stroke

15 (31.3)

21 (21.9)

.221

0.2139

 Congestive heart failure

28 (58.3)

52 (54.2)

.635

0.0827

 Peripheral arterial disease

10 (20.8)

14 (14.6)

.343

0.1629

 COPD

8 (16.7)

18 (18.8)

.759

0.0549

Expenditure in CABG (mean ± SD)

 ICU use (day)

11.06 ± 12.18

7.24 ± 8.89

.058

 

 ICU cost (1000NTD)

28.75 ± 31.80

17.99 ± 21.68

.030

 

 Ventilator use (day)

10.21 ± 12.34

6.40 ± 11.05

.064

 

 Ventilator cost (1000NTD)

15.99 ± 20.09

10.06 ± 17.73

.074

 

 Length of stay (day)

21.47 ± 12.69

17.71 ± 10.07

.094

 

 Surgery cost (1000NTD)

565.20 ± 300.31

421.89 ± 247.74

.010

 

Mortality (%)

 Perioperative

5 (10.4)

2 (2.1)

.028

 

 Postoperative

16 (33.3)

11 (11.5)

.002

 

 Follow-up years (median)

3.10

4.06